These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery. Elmouelhi N; Aich U; Paruchuri VD; Meledeo MA; Campbell CT; Wang JJ; Srinivas R; Khanna HS; Yarema KJ J Med Chem; 2009 Apr; 52(8):2515-30. PubMed ID: 19326913 [TBL] [Abstract][Full Text] [Related]
3. Extracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery. Mathew MP; Tan E; Shah S; Bhattacharya R; Adam Meledeo M; Huang J; Espinoza FA; Yarema KJ Bioorg Med Chem Lett; 2012 Nov; 22(22):6929-33. PubMed ID: 23041156 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological, Physiochemical, and Drug-Relevant Biological Properties of Short Chain Fatty Acid Hexosamine Analogues Used in Metabolic Glycoengineering. Saeui CT; Liu L; Urias E; Morrissette-McAlmon J; Bhattacharya R; Yarema KJ Mol Pharm; 2018 Mar; 15(3):705-720. PubMed ID: 28853901 [TBL] [Abstract][Full Text] [Related]
6. Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells. Campbell CT; Aich U; Weier CA; Wang JJ; Choi SS; Wen MM; Maisel K; Sampathkumar SG; Yarema KJ J Med Chem; 2008 Dec; 51(24):8135-47. PubMed ID: 19053749 [TBL] [Abstract][Full Text] [Related]
7. Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid. Mathew MP; Tan E; Labonte JW; Shah S; Saeui CT; Liu L; Bhattacharya R; Bovonratwet P; Gray JJ; Yarema KJ Chembiochem; 2017 Jul; 18(13):1204-1215. PubMed ID: 28218815 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acyl-modified N-acetylmannosamine analogs in Jurkat cells. Kim EJ; Sampathkumar SG; Jones MB; Rhee JK; Baskaran G; Goon S; Yarema KJ J Biol Chem; 2004 Apr; 279(18):18342-52. PubMed ID: 14966124 [TBL] [Abstract][Full Text] [Related]
9. Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes. Saeui CT; Nairn AV; Galizzi M; Douville C; Gowda P; Park M; Dharmarha V; Shah SR; Clarke A; Austin M; Moremen KW; Yarema KJ PLoS One; 2018; 13(5):e0195812. PubMed ID: 29847599 [TBL] [Abstract][Full Text] [Related]
17. Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs. Aich U; Meledeo MA; Sampathkumar SG; Fu J; Jones MB; Weier CA; Chung SY; Tang BC; Yang M; Hanes J; Yarema KJ Glycoconj J; 2010 May; 27(4):445-59. PubMed ID: 20458533 [TBL] [Abstract][Full Text] [Related]
18. Characterization of ligand binding to the bifunctional key enzyme in the sialic acid biosynthesis by NMR: II. Investigation of the ManNAc kinase functionality. Benie AJ; Blume A; Schmidt RR; Reutter W; Hinderlich S; Peters T J Biol Chem; 2004 Dec; 279(53):55722-7. PubMed ID: 15498763 [TBL] [Abstract][Full Text] [Related]
20. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]